Dashboard
Manage Tickers

ADXN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 12:09:34

Core News & Articles
Earnings Scheduled For September 30, 2025
09/30/2025 08:32:10

addex-therapeutics-q2-eps-290-down-from-1061-yoy
Addex Therapeutics Q2 EPS $(2.90) Down Fro...
09/30/2025 05:22:08

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(2.90) per share. This is a 127.37 percent decrease over earning...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/12/2025 17:06:17

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/12/2025 12:09:50

why-adobe-shares-are-trading-higher-by-over-4-here-are-20-stocks-moving-premarket
Why Adobe Shares Are Trading Higher By Ove...
09/12/2025 09:19:19

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 21:06:02

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/03/2025 12:08:15

earnings-scheduled-for-september-1-2025
Earnings Scheduled For September 1, 2025
09/01/2025 08:32:07

Core News & Articles
Earnings Scheduled For June 19, 2025
06/19/2025 08:32:07

addex-therapeutics-q1-eps-133-up-from-137-yoy-sales-7893k-down-from-26883k-yoy
Addex Therapeutics Q1 EPS $(1.33) Up From ...
06/19/2025 06:39:54

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.33) per share. This is a 2.92 percent increase over losses of...

addex-therapeutics-reports-preclinical-results-for-gabab-pam-demonstrating-superior-efficacy-and-tolerability-in-chronic-cough-models
Addex Therapeutics Reports Preclinical Res...
06/06/2025 06:18:52

addex-therapeutics-to-present-preclinical-data-on-gabab-positive-allosteric-modulator-showing-antitussive-effects-in-guinea-pig-cough-models-at-10th-american-cough-conference
Addex Therapeutics To Present Preclinical ...
06/05/2025 06:18:12

Core News & Articles
Addex Therapeutics Announces Milestone As ...
05/12/2025 06:23:58

addex-expands-dipraglurant-strategy-with-exclusive-ip-access-from-sinntaxis-targeting-brain-injury-functional-recovery
Addex Expands Dipraglurant Strategy With E...
04/30/2025 06:00:28

earnings-scheduled-for-april-25-2025
Earnings Scheduled For April 25, 2025
04/25/2025 08:32:12

addex-therapeutics-fy-2024-gaap-eps-chf-005-down-from-chf-003-yoy-sales-chf-404102k-down-from-chf-1612m-yoy
Addex Therapeutics FY 2024 GAAP EPS CHF (0...
04/25/2025 05:34:58

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of CHF (0.05) per share. This is a 66.67 percent decrease over losse...

Core News & Articles
Earnings Scheduled For April 24, 2025
04/24/2025 08:32:27

Core News & Articles
Earnings Scheduled For April 21, 2025
04/21/2025 08:32:10

addex-therapeutics-regains-full-development-rights-to-adx71149-following-janssen-termination-explores-new-therapeutic-indications
Addex Therapeutics Regains Full Developmen...
04/17/2025 05:13:21

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION